Literature DB >> 29563008

Considerable Heterogeneity.

Matthias Karst, Torsten Passie.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29563008      PMCID： PMC5876544          DOI： 10.3238/arztebl.2018.0143a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  3 in total

Review 1.  Cannabinoids in Pain Management and Palliative Medicine.

Authors:  Winfried Häuser; Mary-Ann Fitzcharles; Lukas Radbruch; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2017-09-22       Impact factor: 5.594

2.  Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

Authors:  John Zajicek; Patrick Fox; Hilary Sanders; David Wright; Jane Vickery; Andrew Nunn; Alan Thompson
Journal:  Lancet       Date:  2003-11-08       Impact factor: 79.321

3.  Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses.

Authors:  Kristian Thorlund; Georgina Imberger; Bradley C Johnston; Michael Walsh; Tahany Awad; Lehana Thabane; Christian Gluud; P J Devereaux; Jørn Wetterslev
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240
  3 in total
  1 in total

1.  [Cannabinoids in pain medicine].

Authors:  M Karst
Journal:  Schmerz       Date:  2018-10       Impact factor: 1.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.